Completed
Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)
NCT04223778
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Georgetown University Hospital ( Site 1018) Washington D.C., District of Columbia, United States
- Midway Immunology and Research ( Site 1030) Ft. Pierce, Florida, United States
- Orlando Immunology Center ( Site 1007) Orlando, Florida, United States
- Bliss Healthcare Services ( Site 1025) Orlando, Florida, United States